Total Payments
$6,074
2024 Payments
$306.51
Companies
28
Transactions
379
Medicare Patients
5,643
Medicare Billing
$357,509
Payment Breakdown by Category
Food & Beverage$5,795 (95.4%)
Education$278.98 (4.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,795 | 376 | 95.4% |
| Education | $278.98 | 3 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,598 | 100 | $0 (2024) |
| Janssen Biotech, Inc. | $975.83 | 82 | $0 (2024) |
| PFIZER INC. | $417.71 | 25 | $0 (2023) |
| LEO Pharma Inc. | $330.18 | 18 | $0 (2023) |
| Lilly USA, LLC | $296.06 | 20 | $0 (2023) |
| Genentech USA, Inc. | $288.32 | 17 | $0 (2023) |
| Amgen Inc. | $225.80 | 12 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $212.88 | 11 | $0 (2024) |
| Galderma Laboratories, L.P. | $210.03 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $193.53 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $306.51 | 17 | ABBVIE INC. ($154.54) |
| 2023 | $1,659 | 107 | AbbVie Inc. ($402.84) |
| 2022 | $2,228 | 142 | ABBVIE INC. ($596.95) |
| 2021 | $760.37 | 51 | AbbVie Inc. ($179.88) |
| 2020 | $13.66 | 1 | Janssen Biotech, Inc. ($13.66) |
| 2019 | $305.83 | 15 | Allergan Inc. ($92.63) |
| 2018 | $361.61 | 23 | AbbVie, Inc. ($90.61) |
| 2017 | $438.84 | 23 | AbbVie, Inc. ($155.18) |
All Payment Transactions
379 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Immunology | ||||||
| 08/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $9.39 | General |
| 03/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Immunology | ||||||
| 03/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: IMMUNOLOGY | ||||||
| 03/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: ACNE | ||||||
| 02/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: IMMUNOLOGY | ||||||
| 02/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.39 | General |
| Category: Immunology | ||||||
| 02/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: IMMUNOLOGY | ||||||
| 01/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: IMMUNOLOGY | ||||||
| 01/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: IMMUNOLOGY | ||||||
| 01/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: IMMUNOLOGY | ||||||
| 01/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Dermatology | ||||||
| 01/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Oncology | ||||||
| 01/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.56 | General |
| Category: Dermatology | ||||||
| 12/22/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: Immunology | ||||||
| 12/19/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Immunology | ||||||
| 12/12/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.78 | General |
| 12/05/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.91 | General |
| Category: Immunology | ||||||
| 12/01/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Immunology | ||||||
| 11/28/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2023 | Sun Pharmaceutical Industries Inc. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Oncology | ||||||
| 11/21/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,361 | 7,022 | $256,410 | $82,610 |
| 2022 | 14 | 1,406 | 11,279 | $279,234 | $92,574 |
| 2021 | 13 | 1,468 | 10,196 | $273,281 | $93,520 |
| 2020 | 14 | 1,408 | 10,498 | $278,064 | $88,805 |
Total Patients
5,643
Total Services
38,995
Medicare Billing
$357,509
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 434 | 507 | $63,882 | $25,915 | 40.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 231 | 266 | $33,250 | $8,483 | 25.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 135 | 150 | $27,450 | $8,034 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 103 | $20,085 | $7,775 | 38.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 93 | 101 | $18,584 | $6,473 | 34.8% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 23 | 4,800 | $14,400 | $6,237 | 43.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 32 | 40 | $9,200 | $3,842 | 41.8% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 23 | 24 | $7,200 | $3,785 | 52.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 175 | 884 | $37,128 | $3,771 | 10.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 33 | $9,240 | $3,515 | 38.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 54 | $5,400 | $1,819 | 33.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 15 | $5,280 | $1,565 | 29.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 31 | $2,511 | $1,100 | 43.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,800 | $296.81 | 10.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 445 | 509 | $64,134 | $26,866 | 41.9% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2022 | 34 | 8,800 | $26,400 | $11,122 | 42.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 250 | 296 | $37,000 | $9,583 | 25.9% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2022 | 34 | 44 | $13,200 | $7,818 | 59.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 116 | 127 | $23,241 | $6,969 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 89 | $17,355 | $6,887 | 39.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 78 | 83 | $15,272 | $5,596 | 36.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 200 | 1,140 | $47,880 | $5,165 | 10.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 29 | 32 | $8,960 | $3,957 | 44.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $8,800 | $2,616 | 29.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 22 | 26 | $5,980 | $2,228 | 37.3% |
About Dr. Donna Roth, M.D
Dr. Donna Roth, M.D is a Dermatology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518964758.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donna Roth, M.D has received a total of $6,074 in payments from pharmaceutical and medical device companies, with $306.51 received in 2024. These payments were reported across 379 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,795).
As a Medicare-enrolled provider, Roth has provided services to 5,643 Medicare beneficiaries, totaling 38,995 services with total Medicare billing of $357,509. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Lexington, KY
- Active Since 07/01/2005
- Last Updated 05/05/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1518964758
Products in Payments
- SKYRIZI (Biological) $813.68
- TREMFYA (Drug) $712.23
- EUCRISA (Drug) $376.38
- TALTZ (Drug) $281.33
- RINVOQ (Biological) $275.81
- Humira (Biological) $263.49
- Erivedge (Biological) $261.05
- HUMIRA (Biological) $235.33
- ADBRY (Biological) $231.04
- Sotyktu (Drug) $193.53
- Cimzia (Drug) $139.76
- DUPIXENT (Biological) $138.34
- OPZELURA (Drug) $120.47
- Enbrel (Biological) $119.77
- STELARA (Biological) $113.28
- Otezla (Drug) $106.03
- LIBTAYO (Biological) $87.33
- ELZONRIS (Drug) $83.59
- REMICADE (Biological) $77.40
- BOTOX COSMETIC (Biological) $74.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Lexington
Dr. Dana Black, M.d, M.D
Dermatology — Payments: $16,936
Dermatology $16,936
Dr. Jonathan Keeling, D.o, D.O
Dermatology — Payments: $13,957
Dermatology $13,957
Gerald Elliott, M.d, M.D
Dermatology — Payments: $13,657
Dermatology $13,657
Carol Thompson, Md, MD
Dermatology — Payments: $9,859
Dermatology $9,859
Dr. Erika Music, Md, MD
Dermatology — Payments: $8,825
Dermatology $8,825
Tessa Mullins, D.o, D.O
Dermatology — Payments: $7,458
Dermatology $7,458